Jim Belardi
Chairman, Chief Executive Officer and Chief Investment Officer, Athene Holding Ltd.
Athene announces launch of IPO - Day 1 employee meeting at Athene USA
A Gift of Hope, Transformational Gift Will Help Accelerate Blood Cancer Research
Jim and Leslie Belardi have made a transformative gift to City of Hope, a leading research and treatment center for cancer and other life threatening diseases. This gift comes 14 years after Jim received a life-saving bone marrow transplant for leukemia at City of Hope.
Blood cancers account for nearly 10% of new cancer cases each year in the United States, yet they are often the most difficult to treat. The gift, representing the largest single contribution to City of Hope for blood cancer research, will support City of Hope’s Hematologic Malignancies Research Institute (HMRI). The gift is targeted at accelerating the development and approval of promising new therapies for some of the most difficult to treat blood cancers.
Belardi Pool at the Avery Aquatic Center, Stanford University


Videos
Tower of Hope – Jim Belardi, CEO of Athene Holding Ltd. and Athene Asset Management, was honored with the Hope Award by the Tower Cancer Research Foundation. The foundation created a video sharing Jim’s story as a leukemia survivor and his passionate zest for life.
City of Hope – video of Dr. Forman, video tribute to Jim and speech by Jim Belardi
James Belardi, CEO of Athene Holding Ltd. and Athene Asset Management, spoke at a fundraiser for Dr. Stephen J. Forman’s research on immunotherapy in New York.
City of Hope – Video of Jim’s family and Jim’s speech
NYSE Advertisement
Bloomberg TV interview on IPO Listing Day